AMN Healthcare Services Inc has a consensus price target of $90.55 based on the ratings of 12 analysts. The high is $121 issued by Credit Suisse on June 16, 2022. The low is $65 issued by B of A Securities on May 15, 2024. The 3 most-recent analyst ratings were released by B of A Securities, BMO Capital, and JMP Securities on May 15, 2024, May 13, 2024, and May 10, 2024, respectively. With an average price target of $70.33 between B of A Securities, BMO Capital, and JMP Securities, there's an implied 11.18% upside for AMN Healthcare Services Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/28/2024 | Buy Now | — | Benchmark | Bill Sutherland | — | Reiterates | → Hold | Get Alert |
05/15/2024 | Buy Now | 2.75% | B of A Securities | Kevin Fischbeck | $61 → $65 | Maintains | Neutral | Get Alert |
05/13/2024 | Buy Now | 12.24% | BMO Capital | Jeffrey Silber | $80 → $71 | Maintains | Outperform | Get Alert |
05/10/2024 | Buy Now | 18.56% | JMP Securities | Constantine Davides | → $75 | Reiterates | Market Outperform → Market Outperform | Get Alert |
05/02/2024 | Buy Now | — | Benchmark | Bill Sutherland | — | Reiterates | → Hold | Get Alert |
04/22/2024 | Buy Now | 10.65% | Truist Securities | Tobey Sommer | $88 → $70 | Maintains | Buy | Get Alert |
02/26/2024 | Buy Now | 18.56% | JMP Securities | Constantine Davides | $87 → $75 | Maintains | Market Outperform | Get Alert |
02/20/2024 | Buy Now | 31.2% | BMO Capital | Jeffrey Silber | $85 → $83 | Maintains | Outperform | Get Alert |
02/16/2024 | Buy Now | 37.53% | JMP Securities | Constantine Davides | $92 → $87 | Maintains | Market Outperform | Get Alert |
12/06/2023 | Buy Now | 34.37% | JMP Securities | Constantine Davides | → $85 | Initiates | → Market Outperform | Get Alert |
12/05/2023 | Buy Now | 39.11% | Truist Securities | Tobey Sommer | → $88 | Reiterates | Buy → Buy | Get Alert |
11/30/2023 | Buy Now | 15.4% | UBS | A.J. Rice | → $73 | Initiates | → Neutral | Get Alert |
11/06/2023 | Buy Now | 39.11% | Truist Securities | Tobey Sommer | $95 → $88 | Maintains | Buy | Get Alert |
11/03/2023 | Buy Now | — | Benchmark | Bill Sutherland | — | Downgrade | Buy → Hold | Get Alert |
11/03/2023 | Buy Now | 10.65% | Jefferies | Brian Tanquilut | $115 → $70 | Downgrade | Buy → Hold | Get Alert |
08/07/2023 | Buy Now | 67.56% | BMO Capital | Jeffrey Silber | $114 → $106 | Maintains | Outperform | Get Alert |
08/04/2023 | Buy Now | 73.89% | Truist Securities | Tobey Sommer | $105 → $110 | Maintains | Buy | Get Alert |
08/04/2023 | Buy Now | 65.98% | Credit Suisse | Jonathan Yong | $115 → $105 | Maintains | Outperform | Get Alert |
08/04/2023 | Buy Now | 64.4% | B of A Securities | Kevin Fischbeck | $112 → $104 | Downgrade | Buy → Neutral | Get Alert |
05/08/2023 | Buy Now | 54.92% | BMO Capital | Jeffrey Silber | $100 → $98 | Maintains | Outperform | Get Alert |
05/05/2023 | Buy Now | 97.6% | Benchmark | Bill Sutherland | $135 → $125 | Maintains | Buy | Get Alert |
05/05/2023 | Buy Now | 81.79% | Credit Suisse | Jonathan Yong | $128 → $115 | Maintains | Outperform | Get Alert |
05/02/2023 | Buy Now | 65.98% | Truist Securities | Tobey Sommer | $140 → $105 | Maintains | Buy | Get Alert |
04/03/2023 | Buy Now | 102.34% | Credit Suisse | Jonathan Yong | $147 → $128 | Maintains | Outperform | Get Alert |
02/21/2023 | Buy Now | 72.3% | BMO Capital | Jeffrey Silber | $130 → $109 | Maintains | Outperform | Get Alert |
02/17/2023 | Buy Now | 132.37% | Credit Suisse | Jonathan Yong | → $147 | Reiterates | → Outperform | Get Alert |
02/17/2023 | Buy Now | 75.47% | Baird | Mark Marcon | $134 → $111 | Maintains | Neutral | Get Alert |
02/13/2023 | Buy Now | 133.96% | Benchmark | Bill Sutherland | → $148 | Reiterates | → Buy | Get Alert |
11/07/2022 | Buy Now | 105.5% | BMO Capital | Jeffrey Silber | $125 → $130 | Maintains | Outperform | Get Alert |
06/16/2022 | Buy Now | 91.27% | Credit Suisse | Nick Giovacchini | $120 → $121 | Maintains | Outperform | Get Alert |
05/24/2022 | Buy Now | 176.64% | Jefferies | Brian Tanquilut | $170 → $175 | Maintains | Buy | Get Alert |
05/06/2022 | Buy Now | 89.69% | Credit Suisse | A.J. Rice | $145 → $120 | Maintains | Outperform | Get Alert |
02/18/2022 | Buy Now | 168.73% | Jefferies | Brian Tanquilut | $140 → $170 | Maintains | Buy | Get Alert |
02/18/2022 | Buy Now | 121.31% | Benchmark | Bill Sutherland | $125 → $140 | Maintains | Buy | Get Alert |
11/17/2021 | Buy Now | 119.73% | Credit Suisse | Nick Giovacchini | — | Maintains | Outperform | Get Alert |
11/08/2021 | Buy Now | 100.76% | BMO Capital | Jeffrey Silber | — | Maintains | Outperform | Get Alert |
08/31/2021 | Buy Now | 105.5% | Truist Securities | Tobey Sommer | — | Maintains | Buy | Get Alert |
08/10/2021 | Buy Now | 81.79% | Credit Suisse | — | — | Maintains | Outperform | Get Alert |
08/09/2021 | Buy Now | 81.79% | BMO Capital | Jeffrey Silber | — | Maintains | Outperform | Get Alert |
The latest price target for AMN Healthcare Services (NYSE:AMN) was reported by Benchmark on May 28, 2024. The analyst firm set a price target for $0.00 expecting AMN to fall to within 12 months (a possible -100.00% downside). 19 analyst firms have reported ratings in the last year.
The latest analyst rating for AMN Healthcare Services (NYSE:AMN) was provided by Benchmark, and AMN Healthcare Services reiterated their hold rating.
There is no last upgrade for AMN Healthcare Services
The last downgrade for AMN Healthcare Services Inc happened on November 3, 2023 when Benchmark changed their price target from N/A to N/A for AMN Healthcare Services Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AMN Healthcare Services, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AMN Healthcare Services was filed on May 28, 2024 so you should expect the next rating to be made available sometime around May 28, 2025.
While ratings are subjective and will change, the latest AMN Healthcare Services (AMN) rating was a reiterated with a price target of $0.00 to $0.00. The current price AMN Healthcare Services (AMN) is trading at is $63.26, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.